__NUXT_JSONP__("/drugs/Tidutamab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"2148354-90-7",chebiId:b,chemicalFormula:b,definition:"A humanized, Fc domain-containing, bispecific monoclonal antibody targeting human CD3, a T-cell surface antigen, and somatostatin receptor 2 (SSTR2), a tumor-associated antigen (TAA) expressed on certain cancer cells, with potential antineoplastic activity. Upon administration, tidutamab binds to both T-cells and SSTR2-expressing cancer cells. The resulting cross-linkage may trigger a potent cytotoxic T-lymphocyte (CTL) response against the SSTR2-expressing cancer cells. The inclusion of an Fc domain on the antibody prolongs the half-life of the bispecific antibody.",fdaUniiCode:"88635FW2QX",identifier:"C146820",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129822","C28227"],synonyms:["Anti-SSTR2 x Anti-CD3 Monoclonal Antibody XmAb18087","TIDUTAMAB",a,"XmAb 18087","XmAb-18087","XmAb18087"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTidutamab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Tidutamab","","2021-10-30T13:32:47.053Z")));